Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
2013: The beginning of the end? Or a new beginning?
This year has been about change; mostly on the regulatory front; both global and at the
New drug target brings malaria cure closer
Scientists discover a chemical modification in the DNA of human malaria parasite
US FDA approves first generic versions of Cymbalta, used in treatment of depression
Indian drug makers to be benefitted
Lilly enters branded generics market with launch of Lil Therapeutics
Announces launch of drugs in breast cancer and colo-rectal cancer segment
Lupin receives FDA approval for Generic Trizivir tabs
Is indicated in combination with other antiretrovirals or alone for the treatment of HIV-1 infection
SIES Institute of Chromatography and Spectroscopy to be soon inaugurated
The institute will subserve the basic objective of rekindling the interest in pure sciences
Glenmark launches Hydrocortisone Butyrate cream in the US
Is entitled to 180 days of exclusivity as it is the first generic company to file an ANDA for the product
CPhI – India, P – MEC-India show path for success
The 2013 edition witnessed participation from 1000 plus exhibitors from 95 countries
Glenmark Pharmaceuticals wins Thomson Reuters India Innovation Award
Wins the Pharma Corporate award while Pharma Academic & Government award went to National Institute of Immunology
CSIR and NII conferred Thomson Reuters Innovation Awards
Glenmark Pharmecuticals makes it to the list of the awards which recognise the most innovative academic institutions and…